SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ting Wang, Jesse C. Hay, Alpha-synuclein Toxicity in the Early Secretory Pathway: How It Drives Neurodegeneration in Parkinsons Disease, Frontiers in Neuroscience, 2015, 9,

    CrossRef

  2. 2
    Chandana Buddhala, Meghan C. Campbell, Joel S. Perlmutter, Paul T. Kotzbauer, Correlation between decreased CSF α-synuclein and Aβ1–42 in Parkinson disease, Neurobiology of Aging, 2015, 36, 1, 476

    CrossRef

  3. 3
    Davide Chiasserini, Silvia Paciotti, Paolo Eusebi, Emanuele Persichetti, Anna Tasegian, Marzena Kurzawa-Akanbi, Patrick F Chinnery, Christopher M Morris, Paolo Calabresi, Lucilla Parnetti, Tommaso Beccari, Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies, Molecular Neurodegeneration, 2015, 10, 1

    CrossRef

  4. 4
    Rebecca M. Perrett, Zoi Alexopoulou, George K. Tofaris, The endosomal pathway in Parkinson's disease, Molecular and Cellular Neuroscience, 2015, 66, 21

    CrossRef

  5. 5
    Florence C. C. Tan, Emmette R. Hutchison, Erez Eitan, Mark P. Mattson, Are there roles for brain cell senescence in aging and neurodegenerative disorders?, Biogerontology, 2014, 15, 6, 643

    CrossRef

  6. 6
    Félix J. Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, José A. G. Agúndez, Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: toward a potential search for biomarkers for this disease, Frontiers in Cellular Neuroscience, 2014, 8,

    CrossRef

  7. 7
    Nadia Magdalinou, Andrew J Lees, Henrik Zetterberg, Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions, Journal of Neurology, Neurosurgery & Psychiatry, 2014, 85, 10, 1065

    CrossRef

  8. 8
    Lucilla Parnetti, Davide Chiasserini, Emanuele Persichetti, Paolo Eusebi, Shiji Varghese, Mohammad M. Qureshi, Andrea Dardis, Marta Deganuto, Claudia Carlo, Anna Castrioto, Chiara Balducci, Silvia Paciotti, Nicola Tambasco, Bruno Bembi, Laura Bonanni, Marco Onofrj, Aroldo Rossi, Tommaso Beccari, Omar El-Agnaf, Paolo Calabresi, Cerebrospinal fluid lysosomal enzymes and alpha-synuclein in Parkinson's disease, Movement Disorders, 2014, 29, 8
  9. 9
    Aida M. Mohammedeid, Vera Lukashchuk, Ke Ning, Protein aggregation and Arfaptin2: A novel therapeutic target against neurodegenerative diseases, New Horizons in Translational Medicine, 2014, 2, 1, 12

    CrossRef

  10. 10
    Dana Kim, Jin Hui Paik, Dong-Woon Shin, Hak-Su Kim, Chang-Shin Park, Ju-Hee Kang, What is the Clinical Significance of Cerebrospinal Fluid Biomarkers in Parkinson's disease? Is the Significance Diagnostic or Prognostic?, Experimental Neurobiology, 2014, 23, 4, 352

    CrossRef